Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
1 other identifier
observational
1,018
1 country
19
Brief Summary
A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2008
Shorter than P25 for all trials
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
April 15, 2008
CompletedFirst Posted
Study publicly available on registry
April 17, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedMay 25, 2009
May 1, 2009
April 15, 2008
May 22, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
Secondary Outcomes (5)
Evaluation of the time period that elapsed since the diagnosis of bipolar disorder
Evaluation of co-morbid psychiatric diseases
Identification of treatment modalities selected according to the disease phase
Identification of the number of first degree relatives diagnosed with bipolar disorder
Evaluation of the relationship between patient and disease characteristics
Study Arms (1)
1
Patients with bipolar disorder
Eligibility Criteria
Speciality care outpatient clinic (Psychiatry outpatient clinic)
You may qualify if:
- Patients previously or currently diagnosed with bipolar disorder
- Patients (or any of their relatives) who give a written informed consent.
You may not qualify if:
- Patients who were previously included in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (19)
Research Site
Adana, Turkey (Türkiye)
Research Site
Afyonkarahisar, Turkey (Türkiye)
Research Site
Ankara, Turkey (Türkiye)
Research Site
Antalya, Turkey (Türkiye)
Research Site
Aydin, Turkey (Türkiye)
Research Site
Batman, Turkey (Türkiye)
Research Site
Denizli, Turkey (Türkiye)
Research Site
Erzincan, Turkey (Türkiye)
Research Site
Eskişehir, Turkey (Türkiye)
Research Site
Istanbul, Turkey (Türkiye)
Research Site
Izmir, Turkey (Türkiye)
Research Site
Konya, Turkey (Türkiye)
Research Site
Malatya, Turkey (Türkiye)
Research Site
Mardin, Turkey (Türkiye)
Research Site
Mersin, Turkey (Türkiye)
Research Site
Rize, Turkey (Türkiye)
Research Site
Samsun, Turkey (Türkiye)
Research Site
Sivas, Turkey (Türkiye)
Research Site
Trabzon, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mustafa Bilici, MD, Assoc. Prof
Erenkoy State Hospital for Psychiatric Diseases, Istanbul, Turkey
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
April 15, 2008
First Posted
April 17, 2008
Study Start
March 1, 2008
Study Completion
March 1, 2009
Last Updated
May 25, 2009
Record last verified: 2009-05